Elequin Capital’s Eli Lilly LLY Stock Holding History

Elequin Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,000	Closed	-$22.9M	–	429
2025 Q3	$22.9M	Buy	+30,000	New	+$22.3M	1.24%	21

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Elequin Capital's LLY Position: Q4 2025 in Review

Elequin Capital sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 30,000 shares — an estimated $22.9M sold.

Elequin Capital first reported a position in LLY in Q2 2024 and held it in 2 quarters. The position peaked at $22.9M in Q3 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

Elequin Capital reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
Elequin Capital sold 30,000 Eli Lilly shares in Q4 2025, an estimated $22.9M.
Elequin Capital first reported a position in Eli Lilly in Q2 2024 and held it in 2 quarters.
Elequin Capital's Eli Lilly position peaked at $22.9M in Q3 2025.
4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Elequin Capital's 13F filing for Q4 2025, filed 17 Feb 2026.